Mamoor, S. (2025). Therapeutic targeting in androgen receptor positive triple negative breast cancer (AR+ TNBC): FGR. Zenodo.
Cita Chicago Style (17a ed.)Mamoor, Shahan. Therapeutic Targeting in Androgen Receptor Positive Triple Negative Breast Cancer (AR+ TNBC): FGR. Zenodo, 2025.
Cita MLA (9a ed.)Mamoor, Shahan. Therapeutic Targeting in Androgen Receptor Positive Triple Negative Breast Cancer (AR+ TNBC): FGR. Zenodo, 2025.
Precaución: Estas citas no son 100% exactas.